Spatial relationship between synapse loss and β-amyloid deposition in Tg2576 mice

Journal of Comparative Neurology

Volumn 500, Issue 2, 2007, Pages 311-321

  Dong, Hongxin ^a   Martin, Maureen V ^a   Chambers, Shawn ^a   Csernansky, John G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid; Alzheimer's disease; Synapse; Synaptophysin; Tg2576 mice

Indexed keywords

BETA AMYLASE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; ELECTRON MICROSCOPY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HIPPOCAMPUS PYRAMIDAL CELL LAYER; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; STEREOMETRY; SYNAPSE; SYNAPSE LOSS; SYNAPTIC EFFICACY; TG2576 MOUSE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL COUNT; DISEASE MODELS, ANIMAL; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; NERVE DEGENERATION; PRESYNAPTIC TERMINALS; SENILE PLAQUES; SYNAPTOPHYSIN;

EID: 33845565678     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21176     Document Type: Article

References (73)

1. Albin RL, Greenamyre JT. 1992. Alternative excitotoxic hypotheses. Neurology 42:733-738.
2. Alvarez P, Zola-Morgan S, Squire LR. 1995. Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys. J Neurosci 15:3796-3807.
3. Bannerman DM, Yee BK, Lemaire M, Wilbrecht L, Jarrard L, Iversen SD, Rawlins JN, Good MA. 2001. The role of the entorhinal cortex in two forms of spatial learning and memory. Exp Brain Res 141:281-303.
4. Barnes P, Good M. 2005. Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene. Behav Brain Res 157:107-117.
5. Bonthius DJ, Bonthius NE, Napper RM, West JR. 1992. Early postnatal alcohol exposure acutely and permanently reduces the number of granule cells and mitral cells in the rat olfactory bulb: a stereological study. J Comp Neurol 324:557-566.
6. Bonthius DJ, McKim R, Koele L, Harb H, Karacay B, Mahoney J, Pantazis NJ. 2004. Use of frozen sections to determine neuronal number in the murine hippocampus and neocortex using the optical disector and optical fractionator. Brain Res Brain Res Protoc 14:45-57.
7. Buckmaster CA, Eichenbaum H, Amaral DG, Suzuki WA, Rapp PR. 2004. Entorhinal cortex lesions disrupt the relational organization of memory in monkeys. J Neurosci 24:9811-9825.
8. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M. 1999. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 96:14088-14093.
9. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK. 1999. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2:271-276.
10. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. 2005. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79-84.
11. DeKosky ST, Scheff SW Styren SD. 1996. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5:417-421.
12. El Khoury J, Hickman SE, Thomas CA, Loike JD, Silverstein SC. 1998. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol Aging 19:381-84.
13. Floden AM, Li S, Combs CK. 2005. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25:2566-2575.
14. Forsyth E, Ritzline PD. 1998. An overview of the etiology, diagnosis, and treatment of Alzheimer disease. Phys Ther 78:1325-1331.
15. Games D, Adams D, Alessandrini R, Barbour R, Berthelotte P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagoplan S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavaia M Mucke L, Paganini L, Penalman E, Power M, Schenk D, Peubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F B-amyloid precursor protein. Nature 373:523-527.
16. Gazzaley AH, Thakker MM, Hof PR, Morrison JH. 1997. Preserved number of entorhinal cortex layer II neurons in aged macaque monkeys. Neurobiol Aging 18:549-653.
17. Geinisman Y, Disterhoft JF, Gundersen HJ, McEchron MD, Persina IS, Power JM, van der Zee EA, West MJ. 2000. Remodeling of hippocampal synapses after hippocampus-dependent associative learning. J Comp Neurol 417:49-59.
18. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL, 2003. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100:10417-10422.
19. Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
20. Guntern R, Bouras C, Hof PR, Vallet PG. 1992. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48:8-10.
21. Hanley T, Merlie JP. 1991. Transgene detection in unpurified mouse tail DNA by polymerase chain reaction. Biotechniques 10:56.
22. Hardy J, Selkoe DJ. 2002: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
23. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100.
24. Hsiao K. 1998. Strain dependent and invariant features of transgenic mice expression Alzheimer amyloid precursor proteins. Prog Brain Res 117: 335-341.
25. Hsiao K. 2001. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem 8:301-308.
26. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274:99-102.
27. Huang SM, Mouri A, Kokubo H, Nakajima R, Suemoto T, Higuchi M, Staufenbiel M, Noda Y, Yamaguchi H, Nabeshima T, Saido TC, Iwata N. 2006. Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J Biol Chem 281:17941-17951.
28. Hynd MR, Scott HL, Dodd PR. 2004. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45:583-595.
29. Irizarry M, McNamara M, Fedorchak K, Hsiao K, Hyman BT. 1997. APPsw transgenic mice develop age-related Ap deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965-973.
30. Jacobs C, Van Den Broeck W, Simoens P. 2005. Quantification of neurons expressing androgen receptor and volume estimation of the basolateral nuclear group of the canine amygdaloid body. Brain Res Brain Res Protoc 15:92-104.
31. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE. 2006. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103:5161-5166.
32. Kennedy MB. 2000. Signal-processing machines at the postsynaptic density. Science 290:750-754.
33. King DL, Arendash GW. 2002. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res 926:58-68.
34. Knowles WD. 1992. Normal anatomy and neurophysiology of the hippocampal formation. J Clin Neurophysiol 9:252-263.
35. Knowles RB, Gomez-Isla T, Hyman BT. 1998. Abeta associated neuropil changes: correlation with neuronal loss and dementia. J Neuropathol Exp Neurol 57:1122-1130.
36. Kokubo H, Kayed R, Glabe CG, Yamaguchi H. 2005. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res 1031: 222-228.
37. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448-6453.
38. Lanz TA, Carter DB, Merchant KM. 2003. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13:246-253.
39. Lesne S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A. 2005. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 25:9367-9377.
40. Lund JS, Griffiths S, Rumberger A, Levitt JB. 2001. Inhibitory synapse cover on the somata of excitatory neurons in macaque monkey visual cortex. Cereb Cortex 11:783-795.
41. Mattson MP. 1997. Cellular actions of beta-amyloid precursor protein and its soluble fibrillogenic derivatives. Physiol Rev 77:1081-1132.
42. McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ. 2003. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J Neurosci 23:2212-2217.
43. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F. 1999. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483-6492.
44. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML. 2004. Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33:377-387.
45. Panegyres PK, Zafiris-Toufexis K, Kakulas BA. 2002. The mRNA of the NR1 subtype of glutamate receptor in Alzheimer's disease. J Neural Transm 109:77-89.
46. Price D. 1986. New perspectives on Alzheimer's disease. Annu Rev Neurosci 9:489-512.
47. Price JL, Morris JC. 1999. Tangles and plaques in nondemented aging and preclinical Alzheimer's disease. Ann Neurol 45:358-368.
48. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B. 1991. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352:239-241.
49. Phinney AL, Calhoun ME, Wolfer DP, Lipp HP, Zheng H, Jucker M. 1999. No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice. Neuroscience 90:1207-1216.
50. Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE. 2003. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci U S A 100:4837-4842.
51. Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, Morabito M, Almeida OF. 2005. Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 30:11061-11070.
52. Rutten BP, Van der Kolk NM, Schafer S, van Zandvoort MA, Bayer TA, Steinbusch HW, Schmitz C. 2005. Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Am J Pathol 167:161-173.
53. Scheff SW, Sparks DL, Price DA. 1996. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia 7:226-232.
54. Selkoe DJ. 1991. Alzheimer's disease. In the beginning. Neuron 6:487-498.
55. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058.
56. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT. 2005. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25:7278-7287.
57. Stern EA, Bacskai BJ, Hickey GA, Attenello FJ, Lombarde JA, Hyman BT. 2004. Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. J Neurosci 24:4535-4540.
58. Su Y, Ni B. 1998. Selective deposition of amyloid-β protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. J Neurosci Res 53:177-186.
59. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK. 2004. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592-3599.
60. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T. 2000. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 157:331-339.
61. Tandrup T, Gundersen HJ, Jensen EB. 1997. The optical rotator. J Microsc 186:108-120.
62. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. 2006. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol 572:477-492.
63. Tsai J, Grutzendler J, Duff K, Gan WB. 2004. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7:1181-1183.
64. Tyszkiewicz JP, Yan Z. 2005. beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J Neurophysiol 93:3102-3111.
65. Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman BT. 2002. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A 99:13990-13995.
66. Wakabayashi K, Narisawa-Saito M, Iwakura Y, Arai T, Ikeda K, Takahashi H, Nawa H. 1999. Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease. Neurobiol Aging 20: 287-295.
67. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. 2002. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30:552-557.
68. Watson AH. 1988. Antibodies against GABA and glutamate label neurons with morphologically distinct synaptic vesicles in the locust central nervous system. Neuroscience 26:33-44.
69. Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, Lipinski WJ, Walker LC, LeVine H. 2001. The role of microglial cells and astrocytes in fibrillar plaque evolution intransgenic APP(SW) mice. Neurobiol Aging 22:49-61.
70. West MJ, Gundersen HJ. 1990. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 296:1-22.
71. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
72. Wiedenmann B, Franke WW. 1985. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41:1017-1028.
73. Wu CC, Chawla F, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE. 2004. Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses. Proc Natl Acad Sci U S A 101:7141-7146.